Skip to main content
Top
Published in: Translational Stroke Research 2/2018

Open Access 01-04-2018 | Original Article

Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial

Authors: Lisa J Woodhouse, Polly Scutt, Shaheen Hamdy, David G Smithard, David L Cohen, Christine Roffe, Daniel Bereczki, Eivind Berge, Christopher F Bladin, Valeria Caso, Hanne K Christensen, Rónán Collins, Anna Czlonkowska, Asita de Silva, Anwar Etribi, Ann-Charlotte Laska, George Ntaios, Serefnur Ozturk, Stephen J Phillips, Kameshwar Prasad, Szabolcs Szatmari, Nikola Sprigg, Philip M Bath

Published in: Translational Stroke Research | Issue 2/2018

Login to get access

Abstract

Post-stroke dysphagia is common, associated with poor outcome and often requires non-oral feeding/fluids. The relationship between route of feeding and outcome, as well as treatment with glyceryl trinitrate (GTN), was studied prospectively. The Efficacy of Nitric Oxide in Stroke (ENOS) trial assessed transdermal GTN (5 mg versus none for 7 days) in 4011 patients with acute stroke and high blood pressure. Feeding route (oral = normal or soft diet; non-oral = nasogastric tube, percutaneous endoscopic gastrostomy tube, parenteral fluids, no fluids) was assessed at baseline and day 7. The primary outcome was the modified Rankin Scale (mRS) measured at day 90. At baseline, 1331 (33.2%) patients had non-oral feeding, were older, had more severe stroke and more were female, than 2680 (66.8%) patients with oral feeding. By day 7, 756 patients had improved from non-oral to oral feeding, and 119 had deteriorated. Non-oral feeding at baseline was associated with more impairment at day 7 (Scandinavian Stroke Scale 29.0 versus 43.7; 2p < 0.001), and worse mRS (4.0 versus 2.7; 2p < 0.001) and death (23.6 versus 6.8%; 2p = 0.014) at day 90. Although GTN did not modify route of feeding overall, randomisation ≤6 h of stroke was associated with a move to more oral feeding at day 7 (odds ratio = 0.61, 95% confidence intervals 0.38, 0.98; 2p = 0.040). As a proxy for dysphagia, non-oral feeding is present in 33% of patients with acute stroke and associated with more impairment, dependency and death. GTN moved feeding route towards oral intake if given very early after stroke.
Clinical Trial Registration
Clinical Trial Registration-URL: http://​www.​controlled-trials.​com. Unique identifier: ISRCTN99414122.
Appendix
Available only for authorised users
Literature
1.
go back to reference Martino R, Foley N, Bhogal S, et al. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke. 2005;36(12):2756–63.CrossRefPubMed Martino R, Foley N, Bhogal S, et al. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke. 2005;36(12):2756–63.CrossRefPubMed
2.
go back to reference Smithard DG, O’Neill PA, Park C, et al. Complications and outcome after acute stroke. Does dysphagia matter? Stroke. 1996;27:1200–4.CrossRefPubMed Smithard DG, O’Neill PA, Park C, et al. Complications and outcome after acute stroke. Does dysphagia matter? Stroke. 1996;27:1200–4.CrossRefPubMed
3.
go back to reference Mann G, Hankey GJ, Cameron D. Swallowing disorders following acute stroke: prevalence and diagnostic accuracy. Cerebrovasc Dis. 2000;10:380–6.CrossRefPubMed Mann G, Hankey GJ, Cameron D. Swallowing disorders following acute stroke: prevalence and diagnostic accuracy. Cerebrovasc Dis. 2000;10:380–6.CrossRefPubMed
4.
go back to reference Smithard D, Smeeton N, Wolfe C. Long-term outcome after stroke: does dysphagia matter? Age Ageing. 2007;36(1):90–4.CrossRefPubMed Smithard D, Smeeton N, Wolfe C. Long-term outcome after stroke: does dysphagia matter? Age Ageing. 2007;36(1):90–4.CrossRefPubMed
6.
go back to reference Wilson R. Mortality and cost of pneumonia after stroke for different risk groups. Journal of Stroke and Cerebrovascular Diseases 2012;21(1) doi: 10.1016/j.jstrokecerebrovasdis.2010.05.002 [published Online First: 2010]. Wilson R. Mortality and cost of pneumonia after stroke for different risk groups. Journal of Stroke and Cerebrovascular Diseases 2012;21(1) doi: 10.1016/j.jstrokecerebrovasdis.2010.05.002 [published Online First: 2010].
7.
go back to reference Rofes L, Arreola V, Almirall J, et al. Diagnosis and management of oropharyngeal dysphagia and its nutritional and respiratory complications in the elderly. Gastroenterol Res Pract. 2011;2011(818979):13. doi:10.1155/2011/818979. Rofes L, Arreola V, Almirall J, et al. Diagnosis and management of oropharyngeal dysphagia and its nutritional and respiratory complications in the elderly. Gastroenterol Res Pract. 2011;2011(818979):13. doi:10.​1155/​2011/​818979.
9.
go back to reference Bülow M, Speyer R, Baijens L, et al. Neuromuscular electrical stimulation (NMES) in stroke patients with oral and pharyngeal dysfunction. Dysphagia. 2008;23(3):302–9.CrossRefPubMed Bülow M, Speyer R, Baijens L, et al. Neuromuscular electrical stimulation (NMES) in stroke patients with oral and pharyngeal dysfunction. Dysphagia. 2008;23(3):302–9.CrossRefPubMed
10.
go back to reference Jayasekeran V, Singh S, Tyrrell P, et al. Adjunctive functional pharyngeal electrical stimulation reverses swallowing disability after brain lesions. Gastroenterology, 2010. 138(5):1737–46. doi:10.1053/j.gastro.2010.01.052. [published Online First: 2010/02/09] Jayasekeran V, Singh S, Tyrrell P, et al. Adjunctive functional pharyngeal electrical stimulation reverses swallowing disability after brain lesions. Gastroenterology, 2010. 138(5):1737–46. doi:10.​1053/​j.​gastro.​2010.​01.​052. [published Online First: 2010/02/09]
12.
13.
go back to reference Perez I, Smithard DG, Davies H, et al. Pharmacological treatment of dysphagia in stroke. Dysphagia. 1998;13(1):12–6. published Online First: 1998/03/07CrossRefPubMed Perez I, Smithard DG, Davies H, et al. Pharmacological treatment of dysphagia in stroke. Dysphagia. 1998;13(1):12–6. published Online First: 1998/03/07CrossRefPubMed
14.
go back to reference Warusevitane A, Karuntilake D, Lally F, et al. Safety and effect of metoclopramide to prevent pneumonia in patients with stroke fed via nasogastric tubes trial. Stroke. 2015;46(2):454–60. Warusevitane A, Karuntilake D, Lally F, et al. Safety and effect of metoclopramide to prevent pneumonia in patients with stroke fed via nasogastric tubes trial. Stroke. 2015;46(2):454–60.
15.
go back to reference Lee J, Chui P, Ma H, et al. Does low dose angiotensin converting enzyme inhibitor prevent pneumonia in older people with neurologic dysphagia—a randomized placebo-controlled trial. J Am Med Dir Assoc. 2015;16(8):702–7. doi:10.1016/j.jamda.2015.05.009. [published Online First: 27Jun 2015]CrossRefPubMed Lee J, Chui P, Ma H, et al. Does low dose angiotensin converting enzyme inhibitor prevent pneumonia in older people with neurologic dysphagia—a randomized placebo-controlled trial. J Am Med Dir Assoc. 2015;16(8):702–7. doi:10.​1016/​j.​jamda.​2015.​05.​009. [published Online First: 27Jun 2015]CrossRefPubMed
16.
go back to reference The ENOS Trial Investigators. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke. 2006;1:245–9.CrossRef The ENOS Trial Investigators. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke. 2006;1:245–9.CrossRef
17.
go back to reference Brainin M, Tuomilehto J, Heiss W-D, et al. Post-stroke cognitive decline: an update and perspectives for clinical research. Eur J Neurol. 2014; Brainin M, Tuomilehto J, Heiss W-D, et al. Post-stroke cognitive decline: an update and perspectives for clinical research. Eur J Neurol. 2014;
18.
go back to reference ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the efficacy of nitric oxide in stroke (ENOS) trial. Int J Stroke. 2014;9(6):711–20. doi:10.1111/ijs.12308. [published Online First: 9th July 2014]CrossRef ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the efficacy of nitric oxide in stroke (ENOS) trial. Int J Stroke. 2014;9(6):711–20. doi:10.​1111/​ijs.​12308. [published Online First: 9th July 2014]CrossRef
19.
go back to reference Bath P, Woodhouse L, Scutt P, et al. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet 2015;385(9968):617–628. doi: http://dx.doi.org/10.1016/S0140-6736(14)61121–61121 [published Online First: 22 October 2014]. Bath P, Woodhouse L, Scutt P, et al. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet 2015;385(9968):617–628. doi: http://​dx.​doi.​org/​10.​1016/​S0140-6736(14)61121–61121 [published Online First: 22 October 2014].
21.
go back to reference Woodhouse L, Scutt P, Krishnan K, et al. Effect of hyperacute administration (within 6 hours) of transdermal glyceryl trinitrate, a nitric oxide donor, on outcome after stroke: subgroup analysis of the efficacy of nitric oxide in stroke (ENOS) trial. Stroke. 2015;46(11):3194–201. doi:10.1161/STROKEAHA.115.009647. [published Online First: 13 Oct 2015]CrossRefPubMed Woodhouse L, Scutt P, Krishnan K, et al. Effect of hyperacute administration (within 6 hours) of transdermal glyceryl trinitrate, a nitric oxide donor, on outcome after stroke: subgroup analysis of the efficacy of nitric oxide in stroke (ENOS) trial. Stroke. 2015;46(11):3194–201. doi:10.​1161/​STROKEAHA.​115.​009647. [published Online First: 13 Oct 2015]CrossRefPubMed
22.
go back to reference Ankolekar S, Fuller M, Cross I, et al. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824). Stroke. 2013;44(11):3120–8. doi:10.1161/strokeaha.113.001301. [published Online First: 2013/09/05]CrossRefPubMed Ankolekar S, Fuller M, Cross I, et al. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824). Stroke. 2013;44(11):3120–8. doi:10.​1161/​strokeaha.​113.​001301. [published Online First: 2013/09/05]CrossRefPubMed
23.
go back to reference Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337(8756):1521–6. [published Online First: 1991/06/22]CrossRefPubMed Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337(8756):1521–6. [published Online First: 1991/06/22]CrossRefPubMed
24.
go back to reference Wei J, Wu T, Yang Q, et al. Nitrates for stable angina: a systematic review and meta-analysis of randomized clinical trials. Int J Cardiol. 2011;146(1):4–12.CrossRefPubMed Wei J, Wu T, Yang Q, et al. Nitrates for stable angina: a systematic review and meta-analysis of randomized clinical trials. Int J Cardiol. 2011;146(1):4–12.CrossRefPubMed
25.
go back to reference Daniels S, Anderson J, Willson P. Valid items for screening dysphagia risk in patients with stroke: a systematic review. Stroke. 2012;43:829–97.CrossRef Daniels S, Anderson J, Willson P. Valid items for screening dysphagia risk in patients with stroke: a systematic review. Stroke. 2012;43:829–97.CrossRef
Metadata
Title
Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial
Authors
Lisa J Woodhouse
Polly Scutt
Shaheen Hamdy
David G Smithard
David L Cohen
Christine Roffe
Daniel Bereczki
Eivind Berge
Christopher F Bladin
Valeria Caso
Hanne K Christensen
Rónán Collins
Anna Czlonkowska
Asita de Silva
Anwar Etribi
Ann-Charlotte Laska
George Ntaios
Serefnur Ozturk
Stephen J Phillips
Kameshwar Prasad
Szabolcs Szatmari
Nikola Sprigg
Philip M Bath
Publication date
01-04-2018
Publisher
Springer US
Published in
Translational Stroke Research / Issue 2/2018
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-017-0548-0

Other articles of this Issue 2/2018

Translational Stroke Research 2/2018 Go to the issue